Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Over the past 2 decades, population simulation modeling has evolved as an effective public
health tool for surveillance of cancer trends and estimation of the impact of screening and …

Abstract Purpose of Review Update on current racial disparities in the detection and
treatment of breast cancer. Recent Findings Breast cancer remains the leading cause of …

Importance Black women with hormone receptor–positive breast cancer experience the
greatest racial disparity in survival of all breast cancer subtypes. The relative contributions of …

Importance There has been little consideration of genomic risk of recurrence by breast
cancer subtype despite evidence of racial disparities in breast cancer outcomes. Objective …

Importance Black women in the United States have higher breast cancer (BC) mortality rates
than White women. The combined role of multiple factors, including body mass index (BMI) …

Importance Adjuvant endocrine therapy (AET) reduces breast cancer recurrence, but
symptom burden is a key barrier to adherence. Black women have lower AET adherence …

The biologic basis of genetic ancestry-dependent variability in disease incidence and
outcome is just beginning to be explored. We recently reported enrichment of a population of …

Purpose The degree to which breast cancer survivors know about their tumors and
understand treatment rationales is not well understood. We sought to identify information …

Abstract Background Populations of African American or Black women have persistently
higher breast cancer mortality than the overall US population, despite having slightly lower …